Board to approve September 2026 quarterly and half-year results

Results View source PDF Explain this filing

BLISSGVS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-3.5%Reaction day

₹642.70

prior close

₹645.10

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-2.3%-1.1% vs market

Pharmaceuticals peers, median of 170sector-1.5%-1.9% vs sector

On the reaction day the stock moved 1.1 pts less than Nifty Microcap 250 and 1.9 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

-0.3

15m

-0.3

30m

-0.8

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-3.5-2.3-1.1-1.5-1.9

Next day

-2.5-1.9-0.6-0.4-2.1

-0.4pendingpending+1.5-2.0

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 170Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The Board will meet on October 29, 2026, to approve the company's unaudited standalone and consolidated results for the quarter and half-year ended September 30, 2026. Trading by covered persons has been closed since October 1 and will reopen 48 hours after the results are announced.

Likely market impact

No financial results or performance figures were provided. Trading remains closed for covered persons until 48 hours after the results announcement.